Jeffrey W. Raser
Fondateur chez Neurana Pharmaceuticals, Inc.
Profil
Jeffrey W.
Raser was the founder of Somaxon Pharmaceuticals, Inc. (founded in 2003) where he held the title of Chief Commercial Officer & SVP-Sales from 2010 to 2011.
Mr. Raser is also the founder of Neurana Pharmaceuticals, Inc...
Mr. Raser's current job is as a Director at OrPro Therapeutics, Inc. Mr. Raser's former jobs include being the Senior Vice President-Sales & Marketing at Women First HealthCare, Inc. from 1998 to 2000, and the SVP-Corporate Development & Marketing at CancerVax Corp.
from 2000 to 2003.
Mr. Raser's education history includes an undergraduate degree from Franklin & Marshall College.
Postes actifs de Jeffrey W. Raser
| Sociétés | Poste | Début |
|---|---|---|
OrPro Therapeutics, Inc.
 OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Fondateur | - |
Anciens postes connus de Jeffrey W. Raser
| Sociétés | Poste | Fin |
|---|---|---|
| CancerVax Corp. | Sales & Marketing | 01/01/2003 |
Women First HealthCare, Inc.
 Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | Sales & Marketing | 01/01/2000 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Fondateur | - |
Formation de Jeffrey W. Raser
| Franklin & Marshall College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | Consumer Services |
| CancerVax Corp. | Commercial Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
OrPro Therapeutics, Inc.
OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |